Navigation Links
Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
Date:5/20/2009

NEW YORK, May 20 /PRNewswire/ -- Carl C. Icahn announced today that three influential independent proxy voting advisory services, RiskMetrics Group, Glass Lewis & Co and PROXY Governance, Inc., have recommended that stockholders of Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) support stockholder nominees for election to the Board of Directors of Amylin's at the 2009 Annual Meeting of Stockholders.

  • RiskMetrics Group has recommended that Amylin stockholders vote FOR the election of our nominee, Dr. Alexander J. Denner and FOR the election of Eastbourne nominees, Dr. Kathleen Behrens and Charles Fleischman.
  • Glass Lewis & Co has recommended that Amylin stockholders vote FOR the election of our nominee Dr. Alexander J. Denner and Eastbourne nominees, Dr. Kathleen Behrens and Jay Sherwood.
  • PROXY Governance, Inc. has recommended Amylin stockholders vote FOR the election of our nominees, Dr. Alexander J. Denner and Dr. Thomas Deuel and Eastbourne nominees, Dr. Kathleen Behrens, Charles Fleischman and Jay Sherwood.

In order to follow any of the above recommendations, which were made by three leading independent proxy voting advisory services, stockholders CANNOT use the blue proxy card since the names of the nominees of Icahn and Eastbourne cannot be written in. To reiterate, stockholders should NOT vote the blue proxy card because the blue proxy card will NOT allow stockholders, among other things, to vote for either of our nominees (Dr. Alexander J. Denner and Dr. Thomas Deuel).

We urge stockholders to use our GOLD proxy card to elect Dr. Alexander J. Denner and Dr. Thomas Deuel. The GOLD proxy card will allow stockholders to vote for Dr. Alexander J. Denner and Dr. Thomas Deuel and will have the effect of voting for the Eastbourne nominees as well as the seven management nominees described thereon. If you wish to withhold authority for any of our nominees or any of the nominees of Eastbourne or any of the seven management nominees you may mark the "for all except" box and write the name of the nominees you do not support.

Stockholders are reminded that they CANNOT vote the blue proxy card to vote for any of our nominees or any of the nominees of Eastbourne and are urged to support our nominees on our GOLD proxy card.

If you have any questions about voting your shares, please call Edward McCarthy or Richard Grubaugh of D.F. King & Co., Inc at (212) 269-5550.

ON MAY 6, 2009, THE PARTICIPANTS FILED A DEFINITIVE PROXY STATEMENT WITH THE SECURITIES AND EXCHANGE COMMISSION. SECURITY HOLDERS ARE ADVISED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER DOCUMENTS RELATED TO THE SOLICITATION OF PROXIES BY CARL C. ICAHN, DR. ALEXANDER J. DENNER, DR. THOMAS F. DEUEL, MAYU SRIS, JEFFREY MECKLER, DR. ERIC ENDE, ICAHN PARTNERS LP, ICAHN PARTNERS MASTER FUND LP, ICAHN PARTNERS MASTER FUND II LP, ICAHN PARTNERS MASTER FUND III LP, ICAHN ENTERPRISES G.P. INC., ICAHN ENTERPRISES HOLDINGS L.P., IPH GP LLC, ICAHN CAPITAL L.P., ICAHN ONSHORE LP, ICAHN OFFSHORE LP, BECKTON CORP., AND CERTAIN OF THEIR RESPECTIVE AFFILIATES FROM THE STOCKHOLDERS OF AMYLIN PHARMACEUTICALS, INC. FOR USE AT ITS ANNUAL MEETING, BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING INFORMATION RELATING TO THE PARTICIPANTS. THE DEFINITIVE PROXY STATEMENT AND A FORM OF PROXY IS AVAILABLE TO STOCKHOLDERS OF AMYLIN PHARMACEUTICALS INC. FROM THE PARTICIPANTS AT NO CHARGE AND IS ALSO AVAILABLE AT NO CHARGE AT THE SECURITIES AND EXCHANGE COMMISSION'S WEBSITE AT HTTP://WWW.SEC.GOV OR BY CONTACTING D.F. KING & CO., INC. BY TELEPHONE TOLL FREE AT 1-800-488-8075.


'/>"/>
SOURCE Carl C. Icahn
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Three Michigan Companies Expand in Ann Arbor with MEDC Support
2. Air Products Sells Three U.S. Healthcare Businesses to Landauer-Metropolitan
3. Swine Flu Closes Three Schools in NYC
4. Study compares formulations of three aspirin types
5. Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009
6. Bertram Receives Organizational Innovation Award at AONE Conference -- Award Sponsor B. E. Smith Also Announces Funding for Three Seed Grants
7. Obama Administration Might Recommend Three Flu Shots for Americans This Fall
8. Three-Quarters of Durable Medical Equipment Providers Have Prepared for Pandemic Flu, According to a May 1 Survey by American Association for Homecare
9. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
10. U.S. Food and Drug Administration Extends Action Date for Inhaled Treprostinil (Tyvaso) New Drug Application by Three Months
11. Pharos Innovations and Clients to Showcase Three Client Case Studies at Upcoming ATA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
(Date:3/23/2017)... Minneapolis, MN (PRWEB) , ... March 23, 2017 , ... ... with internet and WiFi connectivity are making a huge impact on businesses and individual ... Global Institute estimates the IoT will have a value anywhere from $4 trillion to ...
(Date:3/23/2017)... (PRWEB) , ... March 23, ... ... and financial services firm serving the families and businesses of the Norwalk ... enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Management Accreditation from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, ... status is granted to organizations that have excellent programs for the delivery and ...
(Date:3/23/2017)... Scottsdale, AZ (PRWEB) , ... March 23, 2017 , ... ... helping people around the world to manage stress and anxiety. , “Buzzies change ... Serin, neuropsychologist, inventor and co-founder of Buzzies. , Since its launch date in December ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 24, 2017 ShangPharma, a leading ... cost-effective drug development and discovery services, technology, ... industry, announced today the intent for a ... be consolidating the Contract Research Organizations (CRO) ... ChemPartner. These entities include ChemPartner Shanghai, ChemPartner ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... ... very strong with a total of 97 drug candidates. Pharma giant such ... involved in the development of the IPF therapeutics. The IPF pipeline comprised ... 15 are in Phase II stage, 12 are in Phase I stage, ...
(Date:3/24/2017)... -- Global Ampoules Market report provides a ... and industry chain structure. The Ampoules market analysis is ... landscape analysis, and major regions, development status. ... Complete ... 10 company profiles and 183 tables and figures is ...
Breaking Medicine Technology: